Actively Recruiting
Follow-up After Surgery for Testicular Cancer
Led by Erasmus Medical Center · Updated on 2023-02-23
145
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The currently developed implementation study aims to evaluate if a patient-led home-based follow-up approach is successful, improves quality of life, reduces anxiety and lessens fear of cancer recurrence during the years after treatment of certain types of testicular cancer.
CONDITIONS
Official Title
Follow-up After Surgery for Testicular Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Histologically confirmed testicular cancer without distant metastasis and treated with curative intent less than 3 months ago
- For non-seminomatous germ cell tumours, stage I low risk: no lymphadenopathy or metastases on postoperative scan and three consecutive normal tumor marker blood tests
- Patients undergoing lymph node dissection as a second curative operation after orchiectomy with no residual disease or metastases on postoperative scan
- For non-seminomatous germ cell tumours, stage I high risk: completion of one cycle of Bleomycin, etoposide and platinum (BEP) chemotherapy with biochemical remission (three consecutive normal tumor marker tests) and no lymphadenopathy or metastases on CT scan after chemotherapy
- For seminomatous or non-seminomatous germ cell tumours after chemotherapy: biochemical remission with three consecutive normal tumor marker tests and no lymphadenopathy or metastases on CT scan after chemotherapy
- Scheduled or currently undergoing postoperative surveillance according to national and European guidelines
- Signed informed consent
You will not qualify if you...
- Patients with abnormal preoperative LDH levels above 248 U/L
- Patients enrolled in other studies requiring strict follow-up with regular imaging (yearly or more frequent) of abdomen and/or thorax
- Patients with comorbidities or other malignancies requiring imaging of abdomen and/or thorax every year or more frequent
- Inability to complete questionnaires due to illiteracy or insufficient proficiency in Dutch language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasmus Medical Center
Rotterdam, South Holland, Netherlands, 3015GD
Actively Recruiting
Research Team
L
Lissa Wullaert, MD
CONTACT
K
Kelly R. Voigt, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here